-
Surgery & Communication Sciences invites applications for a Postdoctoral Research Associate in cancer epidemiology. Duke TORCHE is a team-based, transdisciplinary lab that uses population lens in
-
laboratory is located in the Duke Cancer Institute (DCI), a collaborative powerhouse—audacious, evolving, unconventional—at the center of a world-renowned university and medical center. DCI unleashes the power
-
interest to analyze genomics data and interpret biomedicine from data; experience or interest in cancer genomics, tumor microenvironment, single-cell data, spatial omics, immunology, gene regulatory networks
-
associate. Dr. Ramanujam is the Director of Duke’s Center for Global Women’s Health Technologies (GWHT). GWHT aspires to make cancer diagnosis, prevention, and treatment more accessible and more effective for
-
with investigators within and outside Duke University. The objectives of the projects are: to identify and validate surrogate endpoints of overall survival using data from cancer clinical trials in
-
of studies of HLA-E-VL9 antibodies in cancer models (in vitro or animals) Other studies on which you and Drs. Haynes and Azoitei agree In addition, you will need to: Present scientific results at meetings and
-
keratinocyte differentiation and cancer biology utilizing cultured cells and animal models of skin diseases. Responsibilities include: Development of new and implementation and modification of existing
-
settings associated with cancer, Alzheimer’s disease, and stroke. Applicants must: 1. Hold a PhD with relevant skillsets in ultrasound imaging; 2. Have excellent informal and formal written and oral
-
, take with them upon obtaining a permanent job after postdoctoral training. The research proposal should be no more than three pages (11-point font, half-inch margins, single spacing; not including
-
common disease areas, including Alzheimer's, brain tumors, and lung cancers. The Postdoc Associate will attend the study team's regular face-to-face or virtual meetings and the meetings with the FDA. We